Jäck, Hans-Martin
Friedrich-Alexander-Universität Erlangen-Nürnberg
4 papers on CoChatORCID 0000-0002-6332-8463
Most cited papers
- Verified
SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies
Hoffmann, M., Arora, P., Groß, R., Seidel, A., Hörnich, B. F., Hahn, A. S., Krüger, N., Graichen, L., Hofmann-Winkler, H., Kempf, A., et al. (2021) · Cell
SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies
Cited by 897
- Verified
The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic
Hoffmann, M., Krüger, N., Schulz, S., Cossmann, A., Rocha, C., Kempf, A., Nehlmeier, I., Graichen, L., Moldenhauer, A.-S., Winkler, M. S., et al. (2022) · Cell
SARS-CoV-2 and COVID-19 Researchvaccines and immunoinformatics approaches
Cited by 889
- Verified
Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)
Cossarizza, A., Chang, H., Radbruch, A., Abrignani, S., Addo, R., Akdis, M., Andrä, I., Andreata, F., Annunziato, F., Arranz, E., et al. (2021) · European Journal of Immunology
T-cell and B-cell ImmunologyMonoclonal and Polyclonal Antibodies Research
Cited by 531
- Verified
SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination
Hoffmann, M., Hofmann-Winkler, H., Krüger, N., Kempf, A., Nehlmeier, I., Graichen, L., Arora, P., Sidarovich, A., Moldenhauer, A.-S., Winkler, M. S., et al. (2021) · Cell Reports
SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies
Cited by 258
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free